Paratesticular rhabdomyosarcoma in young adults: A tertiary care institute experience
Open Access
- 1 January 2013
- journal article
- research article
- Published by Medknow in Indian Journal of Urology
- Vol. 29 (2), 110-113
- https://doi.org/10.4103/0970-1591.114030
Abstract
Introduction: Paratesticular rhabdomyosarcoma (RMS) is a rare tumor arising from the mesenchymal tissues of the spermatic cord, epididymis, testis and testicular tunics. It represents only 7% of all patients entered in the Intergroup Rhabdomyosarcoma Study (IRS) and 17% of all malignant intrascrotal tumors in children less than 15 years old. We present our experience in combined modality management of 10 successive patients of paratesticular RMS. Material and Methods: We retrospectively reviewed 10 patients of paratesticular RMS treated in our institute from July 2004 to December 2010. Clinical characteristics and treatment modality in form of surgery and chemotherapy (CCT) were noted. Statistical analysis was done with regards to progression-free survival (PFS) and overall survival (OS) using Kaplan-Meier survival analysis. Results: The median age of the patients was 16.5 years. The median duration of symptoms was 5 months. Five patients had retroperitoneal lymphadenopathy (RPLAP) while three had lung metastases and one had orbital metastases. All patients underwent high inguinal orchidectomy followed by systemic chemotherapy (CCT). Retroperitoneal node dissection was not a required staging procedure. Four patients had partial response to treatment while six had complete response. Mean duration of PFS was 48 months and mean OS was 56 months. Conclusions: Paratesticular RMS are rare neoplasms with aggressive growth patterns. Cure rates have dramatically improved and 60% of patients in our series had complete response. This success is due to development of multimodality and risk adapted treatment approaches.Keywords
This publication has 17 references indexed in Scilit:
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Treatment of Children With Nonmetastatic Paratesticular Rhabdomyosarcoma: Results of the Malignant Mesenchymal Tumors Studies (MMT 84 and MMT 89) of the International Society of Pediatric OncologyJournal of Clinical Oncology, 2003
- Adult paratesticular tumoursBJU International, 2002
- Paratesticular Rhabdomyosarcoma: Report From the Italian and German Cooperative GroupJournal of Clinical Oncology, 2002
- Intergroup Rhabdomyosarcoma Study-IV: Results for Patients With Nonmetastatic DiseaseJournal of Clinical Oncology, 2001
- THE MANAGEMENT OF PARATESTICULAR RHABDOMYOSARCOMA: A SINGLE INSTITUTIONAL EXPERIENCE WITH 44 CONSECUTIVE CHILDRENJournal of Urology, 1998
- Thirty‐year Review of Intrascrotal RhabdomyosarcomaBJU International, 1991
- Paratesticular Rhabdomyosarcoma: Results of Therapy in 18 CasesJournal of Urology, 1990
- Current Concepts in the Management of Paratesticular RhabdomyosarcomaEuropean Urology, 1985
- Tumors of the EpididymisRecent Results in Cancer Research, 1977